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Fibronectin consists of a series of three internal homology repeats (types I, II, and III [(1983) Proc. Natl. 
Acad. Sci. USA 80, 137-1411). The type III units are each coded for by two exons with the exception of 
the alternatively spliced extra domain type III [(1984) EMBO J. 3, 251 l-25161. To investigate the gene or- 
ganisation of the type I and II repeats, genomic clones covering the collagen-binding domain of human 
fibronectin have been isolated and characterised. The results show that each of the type I and II homology 
units in this region corresponds to an exon. Taken together with the previous data concerning the type III 
units, the data lend support to a gene fusion model of fibronectin evolution. 
(Human) Fibronectin Gene structure CoIlagen binding 
1. INTRODUCTION 
Fibronectin is a ubiquitous extracellular 
glycoprotein that is involved in a variety of cell 
contact processes [ 11. Two major forms of the 
molecule have been distinguished: a plasma form, 
which is a soluble disulphide-linked heterodimer, 
and a cell surface-associated (or cellular) form, 
which consists of dimers and multimers. Each 
subunit of fibronectin has a molecular mass of 
230-250 kDa and contains specific sites for 
binding to cells and a range of macromolecules, in- 
cluding collagens, fibrin and heparin. These 
binding sites have been mapped to a series of 
protease-resistant domains. Partial amino acid se- 
quencing of these fragments has shown that 
fibronectin consists of three types of homologous 
repeats (types I, II and III; [2]). The type I and II 
internal repeats consist of approx. 45 and 60 amino 
acids, respectively, and are stabilised by intrachain 
disulphide bridges, whilst the type III units are 90 
residues long and have no disulphide bonds. The 
binding domains of fibronectin are characterised 
by a particular arrangement of internal repeats, 
implying a functional association between specific 
homology units and binding sites. For example, 
the amino- and carboxy-terminal fibrin-binding 
fragments comprise only type I repeats [2,3], 
whilst the 30-40 kDa collagen-binding domain 
consists of the only two type II units in fibronectin, 
in addition to a number of type I units [4]. 
There is a single fibronectin gene per haploid 
genome in man [5] and rodents [6]. Subunit 
variants of fibronectin are generated by complex 
alternative splicing of the primary transcript [7,8]. 
The repeating structure of the fibronectin polypep- 
tide raises the question of whether this is reflected 
in the organisation of the fibronectin gene. Recent- 
ly it has been established, both for human and rat 
fibronectins, that the type III units are each encod- 
ed by two exons [g-11]. The only exception ap- 
pears to be a unique type III repeat (referred to as 
the extra domain, ED) that undergoes alternative 
splicing and is coded for by a single exon. There is 
some evidence from a study of the chicken 
fibronectin gene that the type I units may corre- 
spond to single exons [12]. However, no informa- 
tion concerning the exon structure of the type II 
repeats has been reported. 
In this paper we describe the isolation of h 
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genomic clones covering approximately the N- 
terminal third of the human fibronectin gene. Se- 
quences corresponding to the collagen-binding do- 
main have been partially characterised. The results 
show that the type I and type II units are each cod- 
ed for by single exons. We discuss the implications 
of this for the evolution of the fibronectin gene 
and the structure of the collagen-binding site of the 
molecule. 
2. MATERIALS AND METHODS 
2.1. Materials 
A partial Mb01 human genomic library in A 
EMBL3 was generously provided by Dr Colin 
Sharpe [13] from this laboratory. The isolation of 
the following human fibronectin cDNA clones has 
been described [14], pFH6, 16, 51 and 134. The 
plasmid pFH16/11 was prepared by subcloning a 
PvuII/RsaI fragment of pFHl6 into 
pAT153/pVuII/8 [15] and corresponds to the two 
type II homology units of fibronectin. Probes were 
either restriction fragments 3 ’ -end-labelled with 
the Klenow fragment of DNA polymerase I [16] 
and eluted from acrylamide gels or eluted from 
agarose gels and nick-translated [17]. 
2.2. Screening of genomic library 
Approx. 4 x lo5 recombinants were screened 
with pFH6 labelled by nick-translation [18]. 
Hybridisation positive signals were re-screened 
separately with pFH6, 51, and 16/11. From nine 
purified plaques, two independent h clones were 
obtained (AFNl and AFN7). 
2.3. Subcloning 
Total HindIll digests of hFN1 and -7 were 
cloned separately into pAT153/pVuII/8 vector and 
two different clones (phFN Hind 1.3 and 5.2) 
which hybridised to pFH16/11 and one (phFH 
Hind 5.5) which hybridised to pFH51 but not 
pFH16/11, were chosen for further analysis. 
2.4. DNA sequencing 
End-labelled fragments were sequenced ac- 
cording to the method of Maxam and Gilbert [ 161. 
3. RESULTS 
3.1. Isolation and characterisation of genomic 
clones for fibronectin 
A series of cDNA clones corresponding to the N- 
terminal 40% of human fibronectin has been 
isolated [14]. One of these clones, pFH6, which 
covers - 1.3 kb from the 5 ‘-end of the coding se- 
quence, was used to isolate two closely overlapping 
genomic clones for fibronectin, named AFNl 
(13.5 kb) and AFN7 (13.0 kb). Dot hybridisation 
experiments indicated that together the clones ex- 
tended from approximately position 600 bp to 
1800 bp in the fibronectin cDNAs [ 141. They thus 
encompassed the sequences coding for collagen- 
binding domains of the protein. Restriction en- 
zyme mapping in conjunction with Southern blot- 
1 kb 
I I 
Fig. 1. Restriction enzyme map of part of the human fibronectin gene showing the position of the type II and flanking 
type I exons. The strategy for sequencing is shown with arrows. Only the Sat861 and HinfI sites in the exons are shown. 
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ting showed that the type II homology units and 
immediately adjacent type I units were contained 
in a series of consecutive Hind111 fragments. These 
were subcloned and the resulting recombinant 
plasmids were mapped in detail; part of this 
restriction map is shown in fig.1. In total the in- 
serts of these subclones covered 12 kb of the 
fibronectin gene and contained the exon sequences 
of both type II homology units together with five 
type I units. 
3.2. Exonhtron organisation 
The nucleotide sequence of the exon/intron 
boundaries of the two type 11s and two flanking 
type I repeats was determined as outlined in fig.1. 
Exon sequences were identical to those reported 
for fibronectin cDNAs [14]. The results showed 
that the type I and II units are encoded by one exon 
each. The 5 ‘-type I exon comprises some non- 
homologous sequence in addition to the type I 
homology. The exon/intron junctions of the 
3 ‘-type I and two type 11s correspond exactly to 
the limits of these units inferred by the alignment 
of the protein sequence (fig.2). All of the splice 
junctions obey the GT/AG rule and all show some 
resemblance to the consensus donor 
(tAG/GT&AGT) and acceptor ([PY]sXCAG/G~) 
sequences [ 191. 
Although the boundaries of three other type I 
units further 5’ and 3’ of the type II repeats were 
I(192 bpl 
yG-~-6__________~_E__T_1 
Qcc~I~~QIGATCTGGC CAAGAGACAGIQI~~QC~~ 
L___________________----A 
II (180 bp) 
~~_~-~-------___-~-~--~-, 
tQttQtaQ;CTGTAACC GACCACACTG IQtQaQlQl 
I ----------__------------ J 
II (177 bpl 
~“__~_-V------____P-_~-A--l 
tctQQcaQ ~TTTTGGTT CCCATGGCTGlQtaaQatg 
L___________________----I 
I(153 bp) 
~A_A--~__~-----__----~--~_~ 
caaaQcaQ ~CCACGAG 
I 
CTTCGAG;QlatQclQ 
-__-------_--------__I 
Fig.2. Sequence of the exon/intron boundaries of the 
type II exons and flanking type I exons. Intron 
sequences are in lower case letters. 
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not analysed, restriction mapping and Southern 
blotting experiments using cDNA probes specific 
for these exons, indicated that each was encoded 
by a single exon (not shown). 
4. DISCUSSION 
In this report the exon structure of the collagen- 
binding domain of fibronectin has been described 
for the first time. Each of the two type II 
homology units, unique to this region, are defined 
by a complete exon. The type I units in this domain 
also represent single exons. It seems likely that all 
the type I units of fibronectin are each coded by an 
exon. Indirect evidence in support of this comes 
from correlating the overall structure of the human 
fibronectin polypeptide deduced from cDNAs [ 141 
with the size of the chicken fibronectin gene. 
Hirano et al. [12] showed, by R-loop mapping, 
that the chicken gene is approx. 50 kb long and 
contains at least 48 exons. Of these, 33 may be ac- 
counted for by the type II and III repeats ([2 type 
II x l] + [IS type III x 21 + [ED x 11) leaving ap- 
prox. 15 exons. Since there are 12 type I units in 
the fibronectin polypeptide, each most probably 
represents a single exon. The size of the exons 
(-130 bp) in the type I homology rich areas of 
chicken fibronectin [12] is consistent with this 
assignment. Thus the modular organisation of the 
fibronectin polypeptide is reflected in the organisa- 
tion of the fibronectin gene. 
It has been suggested that the three types of 
homology in fibronectin originated from three in- 
dependent genes [2]. If so, the contemporary 
fibronectin sequence may be the result of the fu- 
sion and amplification of the three primitive genes, 
with a subsequent process of divergence of the 
original repeats during evolution. These events 
must have occurred well before the divergence of 
vertebrates ince the level of sequence conservation 
between any two homology units of different 
species is much greater than within a species. The 
exact association between the internal repeats and 
exons lends general support to this model of 
fibronectin evolution. The finding that the type III 
homologies are each coded for by two exons shows 
that the position of the intron between these com- 
ponent exons has been remarkably conserved. 
Alternatively it seems possible that fibronectin 
may have originated from four rather than three 
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primordial genes. In any case the ED segment 
seems to be the result of the subsequent fusion of 
two type III exons. 
Indirect evidence supporting a gene fusion 
model of fibronectin evolution comes from an ex- 
amination of the structure of some contemporary 
proteins. Tissue plasminogen activator contains a 
homologous type I repeat [20] which is encoded by 
a single exon [21]. It has also recently been shown 
that human factor XIIa contains a type I unit 
together with a type II homology [22,23]. The type 
II repeat in factor XIIa shows approx. 50% 
homology with the type II repeats of fibronectin 
and is also very similar to two type II sequences 
found in a bovine seminal plasma protein (241. 
From the results presented here we would predict 
that the type II repeats of factor XIIa and the 
bovine protein each correspond to a complete ex- 
on. Thus two of the three building blocks of 
fibronectin have been identified in other proteins, 
suggesting that they arose independently. 
Finally it is interesting to consider the relation- 
ship between the exon structure of the type I and 
II homology units reported here and the functional 
domain which they form. The unique association 
of the type II repeats with the collagen-binding do- 
main strongly suggests that they may be involved 
in the binding activity. We have recently amdysed 
this binding site in human fibronectin using a 
bacterial expression system (Owens and BaraIle, in 
preparation). The results indicate that although 
both type II units and adjacent type Is are pro- 
bably necessary for full binding activity, the actual 
binding specificity for collagen lies within the se- 
cond type II and adjacent type I repeats. Thus the 
binding site is not contained in an exon but is 
generated by the splicing together of adjacent ex- 
ons. Furthermore, it seems that the two type II 
units, though structurally similar at both gene and 
protein level, are not functionally equivalent. A 
similar argument may be made for the type I units 
which feature in both fibrin and collagen-binding 
domains and the type 111s of the cell-attachment 
domain of which only one contains the Arg-Gly- 
Asp-Ser cell-binding signal [ 111. The exon/intron 
boundaries in the fibronectin gene clearly define 
structural units in the protein but do not necessari- 
ly define the functional units. This is consistent 
with the pattern observed in other genes (e.g. 
serine proteases [25]). 
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